Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

29 June 2021 (08:00 - 08:00)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

10 More presentations in this session

Presentation thumbnail

SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial

Doctor K. Aonuma (Tsukuba, JP)

Presentation thumbnail

Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Doctor A. Maggioni (Florence, IT)

Presentation thumbnail

Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States

Doctor M. Vaduganathan (Boston, US)

Presentation thumbnail

Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality

Ms S. Lee (Hong Kong, CN)

Presentation thumbnail

Heart Failure Drug Titration, Discontinuation and Mortality and HF Hospitalization Risk: A Multinational Observational Study (US, UK and Sweden)

Professor G. Savarese (Stockholm, SE)

Access the full session

Session thumbnail

Registry Updates

The Event

Heart Failure 2021

29 June 2021 08:00 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Congress Session

Acute heart failure therapies: from clinical trials to clinical practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources